...
首页> 外文期刊>Cell death & disease. >IGFBP-rP1 suppresses epithelial–mesenchymal transition and metastasis in colorectal cancer
【24h】

IGFBP-rP1 suppresses epithelial–mesenchymal transition and metastasis in colorectal cancer

机译:IGFBP-rP1抑制大肠癌上皮-间质转化和转移

获取原文
           

摘要

Epithelial–mesenchymal transition (EMT) was initially recognized during organogenesis and has recently been reported to be involved in promoting cancer invasion and metastasis. Cooperation of transforming growth factor- β (TGF- β ) and other signaling pathways, such as Ras and Wnt, is essential to inducing EMT, but the molecular mechanisms remain to be fully determined. Here, we reported that insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1), a potential tumor suppressor, controls EMT in colorectal cancer progression. We revealed the inhibitory role of IGFBP-rP1 through analyses of clinical colorectal cancer samples and various EMT and metastasis models in vitro and in vivo . Moreover, we demonstrated that IGFBP-rP1 suppresses EMT and tumor metastasis by repressing TGF- β -mediated EMT through the Smad signaling cascade. These data establish that IGFBP-rP1 functions as a suppressor of EMT and metastasis in colorectal cancer.
机译:上皮-间质转化(EMT)最初是在器官发生过程中被识别的,最近据报道参与促进癌症的侵袭和转移。转化生长因子-β(TGF-β)与其他信号传导途径(如Ras和Wnt)的协同作用对于诱导EMT是必不可少的,但分子机制尚待完全确定。在这里,我们报道了胰岛素样生长因子结合蛋白相关蛋白1(IGFBP-rP1),一种潜在的肿瘤抑制因子,在大肠癌进展中控制着EMT。我们通过分析临床结直肠癌样本以及各种体内外EMT和转移模型揭示了IGFBP-rP1的抑制作用。此外,我们证明了IGFBP-rP1通过通过Smad信号级联抑制TGF-β介导的EMT来抑制EMT和肿瘤转移。这些数据证明IGFBP-rP1可以作为EMT和结直肠癌转移的抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号